{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:44:54Z","timestamp":1795059894022,"version":"4.10.2"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006955","name":"U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR000421"],"award-info":[{"award-number":["KL2TR000421"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA00951528"],"award-info":[{"award-number":["T32 CA00951528"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["5R01CA129517-4"],"award-info":[{"award-number":["5R01CA129517-4"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA141539"],"award-info":[{"award-number":["U01CA141539"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    B cell responses to tumor antigens occur early in breast tumors and may identify immunogenic drivers of tumorigenesis. Sixty-two candidate antigens were identified prior to palpable tumor development in TgMMTV-neu and C3(1)Tag transgenic mouse mammary tumor models. Five antigens (VPS35, ARPC2, SERBP1, KRT8, and PDIA6) were selected because their decreased expression decreased survival in human HER2 positive and triple negative cell lines in a siRNA screen. Vaccination with antigen-specific epitopes, conserved between mouse and human, inhibited tumor growth in both transgenic mouse models. Increased IgG autoantibodies to the antigens were elevated in serum from women with ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC). The autoantibodies differentiated women with DCIS from control with AUC 0.93 (95% CI 0.88\u20130.98,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001). The tumor antigens identified early in the development of breast cancer in mouse mammary tumor models were conserved in human disease, and potentially identify early diagnostic markers in human breast tumors.\n                  <\/jats:p>","DOI":"10.1038\/s41523-021-00257-1","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T06:04:54Z","timestamp":1620713094000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients"],"prefix":"10.1038","volume":"7","author":[{"given":"Sasha E.","family":"Stanton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekram","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Corulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Annis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Hanash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Disis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"257_CR1","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1158\/0008-5472.CAN-15-0248","volume":"75","author":"H Katayama","year":"2015","unstructured":"Katayama, H. et al. An autoimmune response signature associated with the development of triple-negative breast cancer reflects disease pathogenesis. Cancer Res. 75, 3246\u20133254 (2015).","journal-title":"Cancer Res."},{"key":"257_CR2","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1158\/0008-5472.CAN-12-2560","volume":"73","author":"JJ Ladd","year":"2013","unstructured":"Ladd, J. J. et al. Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women. Cancer Res. 73, 1502\u20131513 (2013).","journal-title":"Cancer Res."},{"key":"257_CR3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1158\/1940-6207.CAPR-11-0558","volume":"5","author":"H Lu","year":"2012","unstructured":"Lu, H. et al. Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera. Cancer Prev. Res. 5, 1036\u20131043 (2012).","journal-title":"Cancer Prev. Res."},{"key":"257_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1148\/rg.2019180124","volume":"39","author":"JV Horvat","year":"2019","unstructured":"Horvat, J. V., Keating, D. M., Rodrigues-Duarte, H., Morris, E. A. & Mango, V. L. Calcifications at digital breast tomosynthesis: imaging features and biopsy techniques. Radiographics 39, 307\u2013318 (2019).","journal-title":"Radiographics"},{"key":"257_CR5","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00262-017-2084-x","volume":"67","author":"JA Berzofsky","year":"2018","unstructured":"Berzofsky, J. A. et al. Cancer vaccine strategies: translation from mice to human clinical trials. Cancer Immunol. Immunother. 67, 1863\u20131869 (2018).","journal-title":"Cancer Immunol. Immunother."},{"key":"257_CR6","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1016\/j.vaccine.2019.05.024","volume":"37","author":"SE Stanton","year":"2019","unstructured":"Stanton, S. E., Gad, E., Corulli, L. R., Lu, H. & Disis, M. L. Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets. Vaccine 37, 3552\u20133561 (2019).","journal-title":"Vaccine"},{"key":"257_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2007-8-5-r76","volume":"8","author":"JI Herschkowitz","year":"2007","unstructured":"Herschkowitz, J. I. et al. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8, R76 (2007).","journal-title":"Genome Biol."},{"key":"257_CR8","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10549-014-3199-9","volume":"148","author":"E Gad","year":"2014","unstructured":"Gad, E. et al. Natural history of tumor growth and immune modulation in common spontaneous murine mammary tumor models. Breast Cancer Res. Treat. 148, 501\u2013510 (2014).","journal-title":"Breast Cancer Res. Treat."},{"key":"257_CR9","doi-asserted-by":"publisher","first-page":"101947","DOI":"10.1016\/j.ctrv.2019.101947","volume":"84","author":"C Solinas","year":"2020","unstructured":"Solinas, C., Aiello, M., Migliori, E., Willard-Gallo, K. & Emens, L. A. Breast cancer vaccines: heeding the lessons of the past to guide a path forward. Cancer Treat. Rev. 84, 101947 (2020).","journal-title":"Cancer Treat. Rev."},{"key":"257_CR10","doi-asserted-by":"publisher","first-page":"9545","DOI":"10.1073\/pnas.1121119109","volume":"109","author":"M Toyoshima","year":"2012","unstructured":"Toyoshima, M. et al. Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc. Natl Acad. Sci. USA 109, 9545\u20139550 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"257_CR11","doi-asserted-by":"publisher","first-page":"11236","DOI":"10.1073\/pnas.91.23.11236","volume":"91","author":"IG Maroulakou","year":"1994","unstructured":"Maroulakou, I. G., Anver, M., Garrett, L. & Green, J. E. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc. Natl Acad. Sci. USA 91, 11236\u201311240 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"257_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10552-019-01253-4","volume":"31","author":"S Puvanesarajah","year":"2020","unstructured":"Puvanesarajah, S. et al. Epidemiologic risk factors for in situ and invasive ductal breast cancer among regularly screened postmenopausal women by grade in the Cancer Prevention Study-II Nutrition Cohort. Cancer Causes Control 31, 95\u2013103 (2020).","journal-title":"Cancer Causes Control"},{"key":"257_CR13","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-015-3535-8","volume":"153","author":"A Nassar","year":"2015","unstructured":"Nassar, A. et al. Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study. Breast Cancer Res. Treat. 153, 397\u2013405 (2015).","journal-title":"Breast Cancer Res. Treat."},{"key":"257_CR14","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.aaf1490","volume":"351","author":"N McGranahan","year":"2016","unstructured":"McGranahan, N. et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351, 1463\u20131469 (2016).","journal-title":"Science"},{"key":"257_CR15","first-page":"3189","volume":"41","author":"Z Cheng","year":"2019","unstructured":"Cheng, Z. et al. ARPC2 promotes breast cancer proliferation and metastasis. Oncol. Rep. 41, 3189\u20133200 (2019).","journal-title":"Oncol. Rep."},{"key":"257_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.humpath.2010.03.015","volume":"43","author":"CH An","year":"2012","unstructured":"An, C. H. et al. Frameshift mutations of vacuolar protein sorting genes in gastric and colorectal cancers with microsatellite instability. Hum. Pathol. 43, 40\u201347 (2012).","journal-title":"Hum. Pathol."},{"key":"257_CR17","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1038\/s41388-020-1215-6","volume":"39","author":"G Zhang","year":"2020","unstructured":"Zhang, G. et al. DNA and RNA sequencing identified a novel oncogene VPS35 in liver hepatocellular carcinoma. Oncogene 39, 3229\u20133244 (2020).","journal-title":"Oncogene"},{"key":"257_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-597","volume":"12","author":"NB Serce","year":"2012","unstructured":"Serce, N. B. et al. Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis. BMC Cancer 12, 597 (2012).","journal-title":"BMC Cancer"},{"key":"257_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ygyno.2007.06.023","volume":"107","author":"D Koensgen","year":"2007","unstructured":"Koensgen, D. et al. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression. Gynecol. Oncol. 107, 266\u2013273 (2007).","journal-title":"Gynecol. Oncol."},{"key":"257_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/1354750X.2016.1252952","volume":"22","author":"O Kostianets","year":"2017","unstructured":"Kostianets, O., Shyyan, M., Antoniuk, S. V., Filonenko, V. & Kiyamova, R. Panel of SEREX-defined antigens for breast cancer autoantibodies profile detection. Biomarkers 22, 149\u2013156 (2017).","journal-title":"Biomarkers"},{"key":"257_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cancergencyto.2007.06.002","volume":"178","author":"LC Walker","year":"2007","unstructured":"Walker, L. C. et al. Cytokeratin KRT8\/18 expression differentiates distinct subtypes of grade 3 invasive ductal carcinoma of the breast. Cancer Genet. Cytogenet. 178, 94\u2013103 (2007).","journal-title":"Cancer Genet. Cytogenet."},{"key":"257_CR22","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1073\/pnas.0701145104","volume":"104","author":"K Gumireddy","year":"2007","unstructured":"Gumireddy, K. et al. In vivo selection for metastasis promoting genes in the mouse. Proc. Natl Acad. Sci. USA 104, 6696\u20136701 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"257_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2217\/imt.15.5","volume":"7","author":"SE Stanton","year":"2015","unstructured":"Stanton, S. E. & Disis, M. L. Designing vaccines to prevent breast cancer recurrence or invasive disease. Immunotherapy 7, 69\u201372 (2015).","journal-title":"Immunotherapy"},{"key":"257_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4101-7","volume":"18","author":"PF McAnena","year":"2018","unstructured":"McAnena, P. F. et al. Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options. BMC Cancer 18, 203 (2018).","journal-title":"BMC Cancer"},{"key":"257_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nature10755","volume":"482","author":"H Matsushita","year":"2012","unstructured":"Matsushita, H. et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 482, 400\u2013404 (2012).","journal-title":"Nature"},{"key":"257_CR26","doi-asserted-by":"crossref","unstructured":"Kobayashi, M. et al. Proteome profiling uncovers an autoimmune response signature that reflects ovarian cancer pathogenesis. Cancers 12, 485 (2020).","DOI":"10.3390\/cancers12020485"},{"key":"257_CR27","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1158\/0008-5472.CAN-18-1536","volume":"79","author":"Y Yan","year":"2019","unstructured":"Yan, Y. et al. Whole genome-derived tiled peptide arrays detect prediagnostic autoantibody signatures in non-small-cell lung cancer. Cancer Res. 79, 1549\u20131557 (2019).","journal-title":"Cancer Res."},{"key":"257_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/CBM-190708","volume":"27","author":"C Pagaza-Straffon","year":"2020","unstructured":"Pagaza-Straffon, C. et al. Evaluation of a panel of tumor-associated antigens in breast cancer. Cancer Biomark. 27, 207\u2013211 (2020).","journal-title":"Cancer Biomark."},{"key":"257_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1126\/science.1246886","volume":"343","author":"CG Joseph","year":"2014","unstructured":"Joseph, C. G. et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343, 152\u2013157 (2014).","journal-title":"Science"},{"key":"257_CR30","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.immuni.2004.07.017","volume":"21","author":"GP Dunn","year":"2004","unstructured":"Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137\u2013148 (2004).","journal-title":"Immunity"},{"key":"257_CR31","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1073\/pnas.95.3.1160","volume":"95","author":"KJ Maloy","year":"1998","unstructured":"Maloy, K. J., Odermatt, B., Hengartner, H. & Zinkernagel, R. M. Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection. Proc. Natl Acad. Sci. USA 95, 1160\u20131165 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"257_CR32","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1172\/JCI14451","volume":"108","author":"EM Tan","year":"2001","unstructured":"Tan, E. M. Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J. Clin. Invest. 108, 1411\u20131415 (2001).","journal-title":"J. Clin. Invest."},{"key":"257_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-121","volume":"12","author":"J Mao","year":"2014","unstructured":"Mao, J. et al. Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer. J. Transl. Med. 12, 121 (2014).","journal-title":"J. Transl. Med."},{"key":"257_CR34","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.1158\/1078-0432.CCR-08-3307","volume":"15","author":"C Desmetz","year":"2009","unstructured":"Desmetz, C. et al. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women. Clin. Cancer Res. 15, 4733\u20134741 (2009).","journal-title":"Clin. Cancer Res."},{"key":"257_CR35","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jprot.2009.06.004","volume":"72","author":"C Desmetz","year":"2009","unstructured":"Desmetz, C., Cortijo, C., Mange, A. & Solassol, J. Humoral response to cancer as a tool for biomarker discovery. J. Proteom. 72, 982\u2013988 (2009).","journal-title":"J. Proteom."},{"key":"257_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","volume":"7","author":"LC Hartmann","year":"2014","unstructured":"Hartmann, L. C. et al. Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study. Cancer Prev. Res. 7, 211\u2013217 (2014).","journal-title":"Cancer Prev. Res."},{"key":"257_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.2808","volume":"223","author":"A Bombonati","year":"2011","unstructured":"Bombonati, A. & Sgroi, D. C. The molecular pathology of breast cancer progression. J. Pathol. 223, 307\u2013317 (2011).","journal-title":"J. Pathol."},{"key":"257_CR38","doi-asserted-by":"publisher","first-page":"10578","DOI":"10.1073\/pnas.89.22.10578","volume":"89","author":"CT Guy","year":"1992","unstructured":"Guy, C. T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl Acad. Sci. USA 89, 10578\u201310582 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"257_CR39","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.4049\/jimmunol.177.3.1526","volume":"177","author":"KL Knutson","year":"2006","unstructured":"Knutson, K. L. et al. Immunoediting of cancers may lead to epithelial to mesenchymal transition. J. Immunol. 177, 1526\u20131533 (2006).","journal-title":"J. Immunol."},{"key":"257_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1023\/A:1021175931177","volume":"77","author":"RG Holzer","year":"2003","unstructured":"Holzer, R. G. et al. Development and characterization of a progressive series of mammary adenocarcinoma cell lines derived from the C3(1)\/SV40 Large T-antigen transgenic mouse model. Breast Cancer Res. Treat. 77, 65\u201376 (2003).","journal-title":"Breast Cancer Res. Treat."},{"key":"257_CR41","doi-asserted-by":"publisher","first-page":"9754","DOI":"10.1158\/0008-5472.CAN-06-1083","volume":"66","author":"H Lu","year":"2006","unstructured":"Lu, H., Knutson, K. L., Gad, E. & Disis, M. L. The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens. Cancer Res. 66, 9754\u20139761 (2006).","journal-title":"Cancer Res."},{"key":"257_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1021\/pr049971u","volume":"3","author":"J Qiu","year":"2004","unstructured":"Qiu, J. et al. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J. Proteome Res. 3, 261\u2013267 (2004).","journal-title":"J. Proteome Res."},{"key":"257_CR43","doi-asserted-by":"publisher","first-page":"8400","DOI":"10.1158\/0008-5472.CAN-07-5891","volume":"68","author":"KH Park","year":"2008","unstructured":"Park, K. H. et al. Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer. Cancer Res. 68, 8400\u20138409 (2008).","journal-title":"Cancer Res."},{"key":"257_CR44","doi-asserted-by":"publisher","first-page":"e5013","DOI":"10.1371\/journal.pone.0005013","volume":"4","author":"D Ramduth","year":"2009","unstructured":"Ramduth, D. et al. Immunodominant HIV-1 Cd4+ T cell epitopes in chronic untreated clade C HIV-1 infection. PLoS ONE 4, e5013 (2009).","journal-title":"PLoS ONE"},{"key":"257_CR45","doi-asserted-by":"publisher","unstructured":"Stanton, S. E. et al. Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients. https:\/\/doi.org\/10.6084\/m9.figshare.14333726 (2021).","DOI":"10.6084\/m9.figshare.14333726"}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-021-00257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-021-00257-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-021-00257-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T15:17:27Z","timestamp":1669994247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-021-00257-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["257"],"URL":"https:\/\/doi.org\/10.1038\/s41523-021-00257-1","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"15 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.E.S. has previously had research funding from Precigen through her institution (University of Washington). M.L.D. has stock ownership of VentiRX and Epithany. M.L.D. has received grant funding from EMD Serono, VentiRx, Seattle Genetics, and Celgene. S.H., H.K., E.R., E.G., J.A., and L.C. report no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}